These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1459 related articles for article (PubMed ID: 27097283)

  • 41. Cellular and axonal transport phenotypes due to the C9ORF72 HRE in iPSC motor and sensory neurons.
    Scaber J; Thomas-Wright I; Clark AJ; Xu Y; Vahsen BF; Carcolé M; Dafinca R; Farrimond L; Isaacs AM; Bennett DL; Talbot K
    Stem Cell Reports; 2024 Jul; 19(7):957-972. PubMed ID: 38876108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72.
    Goldman JS; Quinzii C; Dunning-Broadbent J; Waters C; Mitsumoto H; Brannagan TH; Cosentino S; Huey ED; Nagy P; Kuo SH
    JAMA Neurol; 2014 Jun; 71(6):771-4. PubMed ID: 24733620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
    Zhang K; Donnelly CJ; Haeusler AR; Grima JC; Machamer JB; Steinwald P; Daley EL; Miller SJ; Cunningham KM; Vidensky S; Gupta S; Thomas MA; Hong I; Chiu SL; Huganir RL; Ostrow LW; Matunis MJ; Wang J; Sattler R; Lloyd TE; Rothstein JD
    Nature; 2015 Sep; 525(7567):56-61. PubMed ID: 26308891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.
    Shi Y; Lin S; Staats KA; Li Y; Chang WH; Hung ST; Hendricks E; Linares GR; Wang Y; Son EY; Wen X; Kisler K; Wilkinson B; Menendez L; Sugawara T; Woolwine P; Huang M; Cowan MJ; Ge B; Koutsodendris N; Sandor KP; Komberg J; Vangoor VR; Senthilkumar K; Hennes V; Seah C; Nelson AR; Cheng TY; Lee SJ; August PR; Chen JA; Wisniewski N; Hanson-Smith V; Belgard TG; Zhang A; Coba M; Grunseich C; Ward ME; van den Berg LH; Pasterkamp RJ; Trotti D; Zlokovic BV; Ichida JK
    Nat Med; 2018 Mar; 24(3):313-325. PubMed ID: 29400714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis.
    Gao C; Shi Q; Pan X; Chen J; Zhang Y; Lang J; Wen S; Liu X; Cheng TL; Lei K
    Cell Rep; 2024 Mar; 43(3):113892. PubMed ID: 38431841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of five induced pluripotent stem cells lines from four members of the same family carrying a C9orf72 repeat expansion and one wild-type member.
    Lattuada C; Santangelo S; Peverelli S; McGoldrick P; Rogaeva E; Zinman L; Haase G; Géli V; Silani V; Robertson J; Ratti A; Bossolasco P
    Stem Cell Res; 2023 Feb; 66():102998. PubMed ID: 36528014
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.
    Kartanou C; Karadima G; Koutsis G; Breza M; Papageorgiou SG; Paraskevas GP; Kapaki E; Panas M
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):152-154. PubMed ID: 29166782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity.
    Kramer NJ; Haney MS; Morgens DW; Jovičić A; Couthouis J; Li A; Ousey J; Ma R; Bieri G; Tsui CK; Shi Y; Hertz NT; Tessier-Lavigne M; Ichida JK; Bassik MC; Gitler AD
    Nat Genet; 2018 Apr; 50(4):603-612. PubMed ID: 29507424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C9orf72 Gene Expression in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
    Shpilyukova YA; Fedotova EY; Abramycheva NY; Kochergin IA; Zakroyshchikova IV; Zakharova MN; Illarioshkin SN
    Bull Exp Biol Med; 2020 Sep; 169(5):673-676. PubMed ID: 32990847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.
    Fredi M; Cavazzana I; Biasiotto G; Filosto M; Padovani A; Monti E; Tincani A; Franceschini F; Zanella I
    Neuromolecular Med; 2019 Jun; 21(2):150-159. PubMed ID: 30859373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteostasis deregulation as a driver of C9ORF72 pathogenesis.
    Torres P; Cabral-Miranda F; Gonzalez-Teuber V; Hetz C
    J Neurochem; 2021 Dec; 159(6):941-957. PubMed ID: 34679204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia.
    Marques C; Held A; Dorfman K; Sung J; Song C; Kavuturu AS; Aguilar C; Russo T; Oakley DH; Albers MW; Hyman BT; Petrucelli L; Lagier-Tourenne C; Wainger BJ
    Acta Neuropathol; 2024 Mar; 147(1):56. PubMed ID: 38478117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reprogramming fibroblasts and peripheral blood cells from a C9ORF72 patient: A proof-of-principle study.
    Bardelli D; Sassone F; Colombrita C; Volpe C; Gumina V; Peverelli S; Catusi I; Ratti A; Silani V; Bossolasco P
    J Cell Mol Med; 2020 Apr; 24(7):4051-4060. PubMed ID: 32125773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
    Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
    Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD.
    Fu X; Zhang Z; Hayes LR; Wright N; Asbury J; Li S; Ye Y; Sun S
    Exp Neurol; 2024 Jun; 376():114768. PubMed ID: 38556190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
    Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM
    Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Hao Z; Wang R; Ren H; Wang G
    Neurosci Bull; 2020 Sep; 36(9):1057-1070. PubMed ID: 32860626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype.
    Porterfield V; Khan SS; Foff EP; Koseoglu MM; Blanco IK; Jayaraman S; Lien E; McConnell MJ; Bloom GS; Lazo JS; Sharlow ER
    Neurobiol Aging; 2020 Jun; 90():125-134. PubMed ID: 32184029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.